Microsoft PowerPoint - AVNT Q3 2021 Earnings Presentation - WEBSITE AVIENT CORPORATION T H I R D Q U A R T E R 2 0 2 1 R E S U L T S (NYSE: AVNT) O C T O B E R 2 8 , 2 0 2 1 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. A reconciliation of each historical non-GAAP financial measure with the most directly comparable GAAP financial measure is attached to this presentation which is posted on our website at www.avient.com. Q 3 2 0 2 1 P E R F O R M A N C E U P D AT E $74 $99 2020 2021 $0.46 $0.70 2020 2021 Q3 2021 PERFORMANCE ( T O TA L C O M PA N Y ) 4 Sales Adjusted Operating Income $925 $1,220 2020 2021 + 32% Adjusted EPS + 34% + 52% (in millions) (in millions) Q3 2021 SEGMENT PERFORMANCE 5 CAI $494 $587 Sales ($ in millions) SEM Distribution $51 $67 Operating Income +19% +31% $277 $439 Sales $18 $24 Operating Income +58% +33% (1) $174 $234 Sales $25 $32 Operating Income +34% +28% SPECIALTY EBITDA MARGIN EXPANSION 6 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Color acquisition 15.3% 15.2% 16.2% 17.6% 2018 2019 2020 YTD 2021 14.8% 15.2% 17.6% 18.4% 2018 2019 2020 YTD 2021 (1) SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Color synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 7 Legacy CAI 18.9% 18.9% 19.8% 2019 2020 YTD 2021 Legacy Clariant Color 11.9% 13.8% 15.7% 2019 2020 YTD 2021 • Synergy capture driving margin improvement • Favorable mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 35% represents sales from products introduced in the last five years.

To learn more about the Polystrand thermoplastic composites that made the Revolve tripod possible, visit https://www.avient.com/products/advanced-composites. If you’d like assistance with material selection for your applications, contact us.

Microsoft PowerPoint - AVNT Q4 2021 Earnings Presentation (v17) - W PEERS x ESI AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 1 R E S U L T S A N D 2 0 2 2 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A R Y 8 , 2 0 2 2 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. A reconciliation of each historical non-GAAP financial measure with the most directly comparable GAAP financial measure is attached to this presentation which is posted on our website at www.avient.com. O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 6 ) A vi e n t (2 0 2 1 ) A vi e n t (T o d a y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple S U M M A RY: W H Y I N V E S T I N AV I E N T ?

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Available as pre-colored formulation or concentrate and for use in different polymers REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU** APPLICATION BULLETIN * Design note: Effect colors require careful consideration of part design and polymer flow paths to minimize visible flow lines. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

Available in rolls of unidirectional tape as well as X-Ply™ 0°/90° and other multi-ply laminates, Polystrand materials can be post- formed and co-molded with mixed materials in thermoforming and injection molding processes to provide lightweight strength to a variety of part designs. KEY FEATURES • Formulated with 58–80% fiber by weight • Available in rolls of 25 in/63.4 cm wide unidirectional tape, slit widths available up to 2 in/5 cm • Easily recyclable compared to thermoset composites FIBERS FOR POLYSTRAND TAPES • Fiberglass THERMOPLASTIC RESINS • PP • PE • PETG • aPET • PA6 KEY APPLICATIONS • Building & Construction • Automotive • Consumer & Recreation • Oil & Gas PRODUCT BULLETIN 1.844.4AVIENT www.avient.com Copyright © 2024, Avient Corporation.

View PDF The SQS herewith attests that the organisation named below has a management system that meets the requirements of the normative base mentioned. 7 0 0 1 _1 /A p ri l 2 0 2 2 /V er si o n 2 .0 Certificate Avient Colorants MX S.A. de C.V.

Contact your FIBER-LINE® representative for exact product details which conform to your specific requirements. Uranusweg 3 8938 AJ Leeuwarden The Netherlands +31(0) 58 216 75 99 info@fiber-line.com NOTICE: The information and data contained herein do not constitute sales specifications.

Contact your FIBER-LINE® representative for exact product details which conform to your specific requirements. Uranusweg 3 8938 AJ Leeuwarden The Netherlands +31(0) 58 216 75 99 info@fiber-line.com NOTICE: The information and data contained herein do not constitute sales specifications.